The Prelude Network®? (Prelude) announced an expansion of its partnership with Labcorp to serve as its Preferred Genetic Carrier Screening Lab. Labcorp has long been a partner to Prelude and its expansive network of more than 90 clinics across the U.S. and in parts of Canada, providing clinical laboratory and FDA-approved donor testing within each clinic.

The expansion of this partnership delivers another level of genetic carrier screening services to Prelude patients, including in-office phlebotomists and patient service centers. Additionally, Labcorp offers comprehensive genetic counseling, services for provider questions, and complimentary review of carrier screening results for patients. It also capitalizes on a pre-existing interface with electronic medical records for ordering and reporting carrier screening results, improved clarity on reports with variant-specific interpretation, and highly competitive network contract rates for other genetic tests.

To improve financial access to genetic carrier screening for the U.S. patient population, Labcorp is contracted with many insurance companies. This expanded partnership also supports Prelude's Genetic Center of Excellence program and its commitment to offering best-in-class services to patients incorporating genetic testing as part of their care plans. Launched in 2022, one of the initiatives of the Genetic Center of Excellence is to establish standardized, high-quality genetic screening for patients and egg donors in Prelude's network.